Sawakami Tatsuo
Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
Intractable Rare Dis Res. 2021 Nov;10(4):283-287. doi: 10.5582/irdr.2021.01145.
In Japan, specific pediatric chronic diseases include 788 diseases in 16 groups of diseases, 278 categories, and 845 subcategories as of November 1, 2021. The national specific pediatric chronic diseases measures - also called the Medical Aid Program for Chronic Pediatric Diseases of Specified Categories (MAPChD) - was established in Japan in 1974 and enshrined in law in 2005. Patients with specific pediatric chronic diseases can receive government support and welfare in several ways: MAPChD requires diagnosis and medical treatment at designated hospitals and by designated physicians so that patients receive optimal treatment; the copayment rate for medical expenses is reduced to 20% and a maximum is set depending on household income; and the analysis of specific pediatric chronic diseases from different perspectives is continuously being promoted. In addition to these three aspects, various measures are being implemented to provide ongoing support for patients with specific pediatric chronic diseases as they grow up.
在日本,截至2021年11月1日,特定儿科慢性病包括16组疾病中的788种疾病、278个类别和845个子类别。日本的全国特定儿科慢性病措施——也称为特定类别儿童慢性病医疗救助计划(MAPChD)——于1974年设立,并于2005年载入法律。患有特定儿科慢性病的患者可以通过多种方式获得政府支持和福利:MAPChD要求在指定医院由指定医生进行诊断和治疗,以便患者获得最佳治疗;医疗费用的自付率降至20%,并根据家庭收入设定上限;并且不断从不同角度推进对特定儿科慢性病的分析。除了这三个方面,还在实施各种措施,为患有特定儿科慢性病的患者在成长过程中提供持续支持。